Sodium thiosulfate pharmacokinetics in hemodialysis patients and healthy volunteers

Clinical Journal of the American Society of Nephrology

Volumn 6, Issue 6, 2011, Pages 1447-1455

  Farese, Stefan ^a   Stauffer, Emilie ^a   Kalicki, Robert ^a   Hildebrandt, Tatjana ^b   Frey, Brigitte M ^a   Frey, Felix J ^a   Uehlinger, Dominik E ^a   Pasch, Andreas ^a  

^a UNIVERSITY OF BERN   (Switzerland)

^b LEIBNIZ UNIVERSITY HANNOVER   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

SODIUM THIOSULFATE;

ADULT; AGED; ANURIA; AREA UNDER THE CURVE; ARTICLE; ARTIFICIAL KIDNEY; BLOOD SAMPLING; CLINICAL ARTICLE; CONTROLLED STUDY; DIALYSATE; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG CLEARANCE; FEMALE; GLOMERULUS FILTRATION RATE; HEMODIALYSIS; HEMODIALYSIS PATIENT; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; KIDNEY CLEARANCE; MALE; MAXIMUM PLASMA CONCENTRATION; SINGLE DRUG DOSE; STEADY STATE; URINALYSIS;

ADMINISTRATION, ORAL; ADULT; AGED; BIOLOGICAL AVAILABILITY; BIOTRANSFORMATION; CARDIOVASCULAR AGENTS; CHI-SQUARE DISTRIBUTION; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; FEMALE; GLOMERULAR FILTRATION RATE; HUMANS; INJECTIONS, INTRAVENOUS; KIDNEY; KIDNEY DISEASES; MALE; MIDDLE AGED; MODELS, BIOLOGICAL; RENAL DIALYSIS; SWITZERLAND; THIOSULFATES;

EID: 79958194869     PISSN: 15559041     EISSN: 1555905X     Source Type: Journal    
DOI: 10.2215/CJN.10241110     Document Type: Article

References (45)

1. Bhan I, Thadhani R: Vascular calcification and ESRD: A hard target. Clin J Am Soc Nephrol 4: S102-S105, 2009
2. Guerin AP, Blacher J, Pannier B, Marchais SJ, Safar ME, London GM: Impact of aortic stiffness attenuation on survival of patients in end-stage renal failure. Circulation 103: 987-992, 2001
3. Miller MH, Toops TC: Acute cyanide poisoning; recovery with sodium thiosulfate therapy. J Indiana State Med Assoc 44: 1164, 1951
4. Shea M, Koziol JA, Howell SB: Kinetics of sodium thiosulfate, a cisplatin neutralizer. Clin Pharmacol Ther 35: 419-425, 1984
5. Pettersen JC, Cohen SD: Antagonism of cyanide poisoning by chlorpromazine and sodium thiosulfate. Toxicol Appl Pharmacol 81: 265-273, 1985
6. Hildebrandt TM, Grieshaber MK: Three enzymatic activities catalyze the oxidation of sulfide to thiosulfate in mammalian and invertebrate mitochondria. FEBS J 275: 3352-3361, 2008
7. Guerra G, Shah RC, Ross EA: Rapid resolution of calciphylaxiswith intravenous sodium thiosulfate and continuous venovenous haemofiltration using low calcium replacement fluid: Case report. Nephrol Dial Transplant 20: 1260-1262, 2005
8. Brucculeri M, Cheigh J, Bauer G, Serur D: Long-term intravenous sodium thiosulfate in the treatment of a patient with calciphylaxis. Semin Dial 18: 431-434, 2005
9. Landau D, Krymko H, Shalev H, Agronovich S: Transient severe metastatic calcification in acute renal failure. Pediatr Nephrol 22: 607-611, 2006
10. Cicone JS, Petronis JB, Embert CD, Spector DA: Successful treatment of calciphylaxis with intravenous sodium thiosulfate. Am J Kidney Dis 43: 1104-1108, 2004
11. Araya CE, Fennell RS, Neiberger RE, Dharnidharka VR: Sodium thiosulfate treatment for calcific uremic arteriolopathy in children and young adults. Clin J Am Soc Nephrol 1: 1161-1166, 2006
12. Mataic D, Bastani B: Intraperitoneal sodium thiosulfate for the treatment of calciphylaxis. Ren Fail 28: 361-363, 2006
13. Pasch A, Schaffner T, Huynh-Do U, Frey BM, Frey FJ, Farese S: Sodium thiosulfate prevents vascular calcifications in uremic rats. Kidney Int 74: 1444-1453, 2008
14. Adirekkiat S, Sumethkul V, Ingsathit A, Domrongkitchaiporn S, Phakdeekitcharoen B, Kantachuvesiri S, Kitiyakara C, Klyprayong P, Disthabanchong S: Sodium thiosulfate delays the progression of coronary artery calcification in haemodialysis patients. Nephrol Dial Transplant 25: 1923-1929, 2010
15. Schlieper G, Brandenburg V, Ketteler M, Floege J: Sodium thiosulfate in the treatment of calcific uremic arteriolopathy. Nat Rev Nephrol 5: 539-543, 2009
16. Mendoza FJ, Lopez I, Montes de Oca A, Perez J, Rodriguez M, Aguilera-Tejero E: Metabolic acidosis inhibits soft tissue calcification in uremic rats. Kidney Int 73: 407-414, 2008
17. O'Neill WC: Treatment of vascular calcification. Kidney Int 74: 1376-1378, 2008
18. Chen K, Rose C, Gha C: Comparative values of several antidotes in cyanide poisoning. Am J Med Sci 188: 767-781, 1934
19. Newton GL, Dorian R, Fahey RC: Analysis of biological thiols: Derivatization with monobromobimane and separation by reverse-phase high-performance liquid chromatography. Anal Biochem 114: 383-387, 1981
20. Völkel S, Grieshaber MK: Oxgen dependent sulfide detoxification in the lugworm Arenicol marina. Mar Biol 118: 137-147, 1994
21. Benet LZ, Galeazzi RL: Noncompartmental determination of the steady-state volume of distribution. J Pharm Sci 68: 1071-1074, 1979
22. Perrier D, Gibaldi M: General derivation of the equation for time to reach a certain fraction of steady state. J Pharm Sci 71: 474-475, 1982
23. Frey FJ, Frey BM: Altered plasma protein-binding of prednisolone in patients with the nephrotic syndrome. Am J Kidney Dis 3: 339-348, 1984
24. Lindbom L, Pihlgren P, Jonsson EN: PsN-Toolkit-a collection of computer intensive statistical methods for non-linear mixed effect modeling using NONMEM. Comput Methods Programs Biomed 79: 241-257, 2005
25. Jonsson EN, Karlsson MO: Xpose-an S-PLUS based population pharmacokinetic/pharmacodynamic model building aid for NONMEM. Comput Methods Programs Biomed 58: 51-64, 1999
26. Rowan FE, Docherty NG, Coffey JC, O'Connell PR: Sulphatereducing bacteria and hydrogen sulphide in the aetiology of ulcerative colitis. Br J Surg 96: 151-158, 2009
27. Berglund F, Helander CG, Howe RB: Inorganic sulfate and thiosulfate: Transport and competition in renal tubules of the dog. Am J Physiol 198: 586-594, 1960
28. Yatzidis H: Gestational urinary hyperthiosulfaturia protects hypercalciuric normal pregnant women from nephrolithiasis. Int Urol Nephrol 36: 445-449, 2004
29. Asplin JR, Donahue SE, Lindeman C, Michalenka A, Strutz KL, Bushinsky DA: Thiosulfate reduces calcium phosphate nephrolithiasis. J Am Soc Nephrol 20: 1246-1253, 2009
30. Musso CG, Enz P, Vidal F, Gelman R, Di Giuseppe L, Bevione P, Garfi L, Galimberti R, Algranati L: Oral sodium thiosulfate solution as a secondary preventive treatment for calciphylaxis in dialysis patients. Saudi J Kidney Dis Transpl 19: 820-821, 2008
31. Agroyannis B, Tzanatos H, Vlahakos DV, Mallas E: Does long-term administration of sodium thiosulphate inhibit progression to renal failure in nephrocalcinosis? Nephrol Dial Transplant 16: 2443-2444, 2001
32. Newman E, Gilman A, Philips F: The renal clearance of thiosulfate in man. Bull Johns Hopkins Hosp 79: 229-242, 1946
33. Gilman A, Philips F, Koelle E: The renal clearance of thiosulfate with observations on its volume distribution. Am J Physiol 146: 348-357, 1946
34. Braverman B, Ivankovich AD, Shah G: Thiosulfate pharmacokinetics in normal and anuric dogs. Proc Soc Exp Biol Med 170: 273-280, 1982
35. Scherrer S, Haldimann B, Kupfer A, Reubi F, Bircher J: He- 1454 Clinical Journal of the American Society of Nephrology patic metabolism of aminopyrine in patients with chronic renal failure. Clin Sci Mol Med 54: 133-140, 1978
36. Horber FF, Frey FJ, Descoeudres C, Murray AT, Reubi FC: Differential effect of impaired renal function on the kinetics of clavulanic acid and amoxicillin. Antimicrob Agents Chemother 29: 614-619, 1986
37. Frey FJ, Schaad HJ, Renner EL, Horber FF, Frey BM, Preisig R: Impaired liver function in stable renal allograft recipients. Hepatology 9: 606-613, 1989
38. Schulz V: Clinical pharmacokinetics of nitroprusside, cyanide, thiosulphate and thiocyanate. Clin Pharmacokinet 9: 239-251, 1984
39. Bartholomew TC, Powell GM, Dodgson KS, Curtis CG: Oxidation of sodium sulphide by rat liver, lungs and kidney. Biochem Pharmacol 29: 2431-2437, 1980
40. Szczepkowski TW, Skarzynski B, Weber M: The metabolic state of thiosulphate. Nature 189: 1007-1008, 1961
41. Frey FJ: Pharmacokinetic determinants of cyclosporine and prednisone in renal transplant patients. Kidney Int 39: 1034-1050, 1991
42. Hayden MR, Tyagi SC, Kolb L, Sowers JR, Khanna R: Vascular ossification-calcification in metabolic syndrome, type 2 diabetes mellitus, chronic kidney disease, and calciphylaxiscalcific uremic arteriolopathy: The emerging role of sodium thiosulfate. Cardiovasc Diabetol 4: 4, 2005
43. Schurgers LJ, Barreto DV, Barreto FC, Liabeuf S, Renard C, Magdeleyns EJ, Vermeer C, Choukroun G, Massy Z: The circulating inactive form of matrix gla protein is a surrogate marker for vascular calcification in chronic kidney disease: A preliminary report. Clin J Am Soc Nephrol 5: 568-575, 2010
44. Ketteler M, Giachelli C: Novel insights into vascular calcification. Kidney Int 105: S5-S9, 2006
45. Charlson ME, Pompei P, Ales KL, MacKenzie CR: A new method of classifying prognostic comorbidity in longitudinal studies: Development and validation. J Chronic Dis 40: 373-383, 1987